昌吉二十多岁性功能障碍怎么办昌吉医院泌尿科,昌吉做人流手术医院那里好,昌吉包皮整形手术的价格,昌吉阴茎勃起时间短是怎么回事,昌吉男科看包皮包茎,昌吉市最有权威的女子医院,昌吉市哪家妇科医院最好

WASHINGTON, Aug. 10 (Xinhua) -- After a journey of almost three years, NASA's Mars rover Opportunity has reached the Red Planet's Endeavour crater to study rocks never seen before, the U.S. National Aeronautics and Space Administration (NASA) announced on Wednesday.Scientists hope it will find rocks and terrain much older than any other that the itinerant robot has examined during its seven years on the red planet.The U.S. space agency said that Opportunity arrived at the rim of Endeavour on Tuesday. The golf cart-size rover is expected to remain at the 22-kilometer-wide crater for the next few years.A portion of the west rim of Endeavour crater sweeps southward in this color view from NASA's Mars Exploration Rover Opportunity."NASA is continuing to write remarkable chapters in our nation' s story of exploration with discoveries on Mars and trips to an array of challenging new destinations," NASA Administrator Charles Bolden said in a statement. "Opportunity's findings and data ... will play a key role in making possible future human missions to Mars and other places where humans have not yet been."NASA's Mars Reconnaissance Orbiter, which has been circling the planet since late 2005, detected clay minerals that form in wet conditions in the crater. Scientists want to find out if the minerals date back to Mars' distant past, when the planet is believed to have been wetter and warmer than the dry frozen desert it is today."We're soon going to get the opportunity to sample a rock type the rovers haven't seen yet," said Matthew Golombek, Mars Exploration Rover science team member, at NASA's Jet Propulsion Laboratory in Pasadena, Calif. "Clay minerals form in wet conditions so we may learn about a potentially habitable environment that appears to have been very different from those responsible for the rocks comprising the plains."NASA is searching for signs that Mars had a habitable environment billions of years ago. Knowledge of the Martian climate will be important to future manned missions there, and can shed light on the forces that shaped Earth's climate.NASA launched the Mars rovers Opportunity and Spirit in 2003 for what were planned to be three-month missions. But both continued operating well beyond that. Spirit stopped communicating in March 2010.

THE HAGUE, Aug. 16 (Xinhua) -- ESBL-enzymes, which are known for their ability to stop the effects of antibiotics, can directly pass from chicken to people, said a research published on Tuesday.Veterinary researcher Dik Mevius of the Wageningen University released the finding in the magazine Resource.The research group led by Mevius has isolated six ESBL-genes varieties and compared them to bacteria found on hospital patients, on super market poultry and in laying batteries. In 35 percent of all cases, they discovered a match of 100 percent.Bacteria like Klebsiella on E. coli can produce the ESBL-enzymes. A healthy person will not feel any effect, but people with a lower immune system can get very sick. In areas like a hospital, the infection can easily spread."The main concern is that the enzyme resists the most used antibiotics, which makes the treatment of infected persons difficult," said Mevius.According to Mevius, 94 percent of supermarket poultry carries the enzyme, but all enzymes will be killed during the heating process of cooking.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.

BUDAPEST, June 25 (Xinhua) -- Visiting Chinese Premier Wen Jiabao made a five-point proposal here Saturday to enhance China's cooperation with countries in Central and Eastern Europe.When delivering a speech at the China-Central and East European Countries Economic and Trade Forum, Wen said China cherished its longstanding and deep friendship with the countries in the region."Over the past several decades, although the international situation and the domestic situations of both sides have undergone big changes, we have always enjoyed mutual respect, mutual trust, mutual understanding and mutual support," Wen said. Chinese Premier Wen Jiabao addresses the China-Central and Eastern European Countries Economic and Trade Forum in Budapest, Hungary, June 25, 2011.He said cooperation in various fields between the two sides had made tremendous progress, referring to the rapid growth of two-way trade, the burgeoning of mutual investment, the expansion of cooperation areas and the improvement of cooperation mechanisms.China encouraged its companies to "go global" and saw Central and Eastern Europe as a strategic priority, the Chinese leader said, adding that his current visit was "both a journey of friendship and a journey of cooperation."

WASHINGTON, Sept. 13 (Xinhua) -- The U.S. Department of Health and Human Services (HHS), with several partners, on Tuesday launched Million Hearts, an initiative that aims to prevent one million heart attacks and strokes over the next five years.The program will focus on helping Americans make healthy choices, such as preventing tobacco use and lowering consumption of salt and trans fats, and increasing use of treatments like aspirin and blood pressure and cholesterol-lowering medications.The HHS hopes that by 2017, 65 percent of high-risk patients will be taking aspirin and have their blood pressure and cholesterol under control. Currently, only 47 percent of high-risk patients take aspirin, and only 33 percent have their cholesterol and 46 percent their blood pressure under control.They also aim to cut smoking to 17 percent of Americans from 19 percent by 2017, and seek a 20 percent drop in sodium intake and a 50 percent drop in trans fat consumption."Heart disease causes one of every three American deaths and constitutes 17-percent of overall national health spending," said HHS Secretary Kathleen Sebelius in a statement. "By enlisting partners from across the health sector, Million Hearts will create a national focus on combating heart disease."